Amryt Pharma Share Price Deutsche Boerse AG

Stocks

Delayed Deutsche Boerse AG			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

22/21/22	Amryt Pharma to Delist from LSE's Main Market in January 2022	MT
13/21/13	Amryt Pharma : Boosts FY21 Revenue Guidance Following Chiasma Purchase	MT

22/21/22	Amryt Pharma to Delist from LSE's Main Market in January 2022	MT
13/21/13	Amryt Pharma : Boosts FY21 Revenue Guidance Following Chiasma Purchase	MT
06/21/06	Amryt Pharma : Hikes FY21 Guidance As H1 Loss Narrows On Strong Growth	MT
05/21/05	Amryt Pharma : Completes Acquisition Of Chiasma	MT
29/21/29	Novacyt : CEO to Retire; Amryt Pharma Exec Named Successor	MT
28/21/28	Amryt Pharma : Sends Invitation To Shareholders To Vote For Chiasma Acquisition	MT
03/21/03	Amryt Pharma : Wins US FDA's Priority Review Status For Rare Genetic Skin Disorder Drug	MT
02/21/02	Amryt Pharma : Receives New Drug Application Status For Oleogel-S10 In US	MT
31/21/31	Amryt Pharma : Submits New Rare Disease Drug for US FDA Approval	MT
30/21/30	Amryt Pharma : Reports Encouraging Results From Familial Chylomicronaemia Syndrome Drug Trial	MT
29/21/29	Amryt Pharma : Shares Rise 5% on European Medicines Agency Progress for Skin Disorder Drug	MT
23/21/23	Amryt Pharma : Seeks to Double Leptin Deficiency Drug Myalepta's Market Share in US	MT
22/21/22	Amryt Pharma : Myalepta Receives Reimbursement Approval in France	MT

Employees

Sector